Aurobindo Pharma USA Inc. recalls Clorazepate Dipotassium Tablets, USP, 3.75 mg, a) 100 tablets per bottle, NDC 13107-282-01 b) 500 tablets per bottle, ND
Recalled May 15, 2024 · FDA recall D-0491-2024 · Aurobindo Pharma USA
Hazard
Discoloration: Dotted and yellow spots on tablets · FDA Class II
Units
6696 bottles
Sold at
Nationwide in the USA
Description
Discoloration: Dotted and yellow spots on tablets
Product
Clorazepate Dipotassium Tablets, USP, 3.75 mg, a) 100 tablets per bottle, NDC 13107-282-01 b) 500 tablets per bottle, NDC 13107-282-05, Rx Only, Distributed by Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India.
Manufacturer(s)
Aurobindo Pharma USA Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →